Description: Universal Ibogaine Inc. provides treatment for addiction patients in Canada. It provides ibogaine addiction treatment to patients suffering from opioid addiction; and operates clinics that offer non-medical detox, inpatient and outpatient treatment, and aftercare recovery programs, as well as addiction intervention services. The company was incorporated in 2018 and is based in Vancouver, Canada.
Home Page: universalibogaine.com
400 3rd Avenue SW
Calgary,
AB
T2P 4H2
Canada
Phone:
855-426-4246
Officers
| Name | Title |
|---|---|
| Dr. Alberto Sola Agullo M.D., Ph.D. | Co-Founder, Pres & Director |
| Mr. Shayne Nyquvest | Co-Founder |
| Mr. Greg J. Leavens C.A., CPA | CFO & Corp. Sec. |
| Mr. Nicholas Peter Karos | CEO, Director of Capital Markets & Director |
| Ms. Colleen Clandening | Director of Operations |
| Mr. Dugan Selkirk | Mang. Communications & Investor Relations |
| Cathy Fernandes | VP of Marketing & VP of Communications |
| Dr. Ian Rabb | Chief Clinics Officer |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2513 |
| Price-to-Sales TTM: | 3.6725 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |